025320 — Synopex Balance Sheet
0.000.00%
- KR₩568bn
- KR₩557bn
- KR₩238bn
Annual balance sheet for Synopex, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | ARS | Annual Audited Accounts |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Cash and Equivalents | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 17,478 | 15,568 | 29,578 | 27,402 | 46,179 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 24,123 | 35,029 | 26,547 | 24,251 | 22,062 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 64,525 | 84,867 | 94,460 | 83,568 | 99,611 |
Net Property, Plant And Equipment | 89,459 | 100,512 | 107,852 | 107,995 | 122,441 |
Net Goodwill | |||||
Net Intangible Assets | |||||
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 163,474 | 202,614 | 214,865 | 201,314 | 235,414 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Current Portion of Long Term Debt / Capital Leases | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 80,860 | 106,763 | 96,229 | 54,301 | 60,470 |
Long Term Debt | |||||
Capital Lease Obligations | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Minority Interest | |||||
Total Other Liabilities | |||||
Total Funded Status | |||||
Total Liabilities | 88,152 | 113,980 | 109,929 | 67,093 | 67,629 |
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Treasury Stock | |||||
ESOP Debt Guarantee | |||||
Unrealized Gain / Loss | |||||
Other Equity | |||||
Total Equity | 75,322 | 88,634 | 104,936 | 134,221 | 167,784 |
Total Liabilities & Shareholders' Equity | 163,474 | 202,614 | 214,865 | 201,314 | 235,414 |
Total Common Shares Outstanding |